| name | es-preop-hba1c-factors |
| description | Consider factors that may affect hemoglobin A1c when interpreting preoperative levels for adults with diabetes undergoing elective surgery. Triggered by questions such as "Are there conditions that might make HbA1c unreliable for this patient?" when anemia, hemoglobinopathies, chronic renal failure, alcoholism, drugs, or large blood glucose variations are present. |
Consider factors that may affect hemoglobin A1c when interpreting preoperative levels
STEP 1 — Gather Information
Collect patient's HbA1c, recent blood glucose values, history of anemia (e.g., iron deficiency, B12/folate deficiency, hemolysis), hemoglobinopathies (sickle cell, thalassemia), chronic renal failure (eGFR <60 mL/min/1.73m²), alcoholism, medications that affect HbA1c (e.g., opioids, high-dose vitamin C/E, antiretrovirals), and assess for large glucose variations (wide swings, frequent hypoglycemia/hyperglycemia).
STEP 2 — Rule In / Rule Out
Determine if any factor that could affect HbA1c reliability is present. If none, HbA1c can be used reliably; if any factor present, HbA1c may be unreliable.
STEP 3 — Classify or Stratify
If HbA1c deemed unreliable, classify patient for reliance on preoperative blood glucose targets; if reliable, proceed with HbA1c-based target.
STEP 4 — Decide
If HbA1c unreliable, target preoperative blood glucose 100–180 mg/dL (5.6–10 mmol/L) and consider repeating HbA1c after addressing factor or using alternative glycemic markers; if reliable, target preoperative HbA1c <8% (63.9 mmol/mol) and blood glucose 100–180 mg/dL.
Clinical Guardrails / Mimics / Pitfalls
Do not rely solely on HbA1c in patients with anemia, hemoglobinopathies, renal failure, alcoholism, or drug effects; do not ignore large glucose fluctuations that may mask chronic hyperglycemia; do not assume HbA1c reflects recent glycemic control when erythrocyte turnover is altered; avoid using HbA1c to deny surgery if unreliable without confirming with glucose metrics.
Concrete Clinical Example
A 68-year-old with type 2 diabetes and CKD stage 3b (eGFR 38) scheduled for elective hip replacement has HbA1c 7.6% but recent glucose logs show frequent hypoglycemia (<70 mg/dL) and hyperglycemia (>250 mg/dL). Given chronic renal failure and glucose variability, HbA1c is deemed unreliable; the team targets preoperative glucose 100–180 mg/dL and proceeds with surgery after achieving stable glucose in that range for 24 hours.
Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278
